Company Filing History:
Years Active: 2018
Title: Juned Dalal: Innovator in Oligosaccharide-Protein Conjugation
Introduction
Juned Dalal is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of synthetic oligosaccharide-protein conjugates. His innovative work focuses on improving processes that enhance the immunogenicity of vaccines.
Latest Patents
Juned Dalal holds a patent for the "Process of conjugation and novel synthetic oligosaccharide-protein conjugates obtained thereof." This invention relates to an improved process of conjugation that results in synthetic oligosaccharide-protein (OS-PR) conjugates. The process is rapid and yields highly immunogenic conjugates that elicit specific and homogenous immune responses. The synthetic oligosaccharide consists of four to eight repeating units of respective monomers and includes at least one in-built terminal amino linker. This synthetic polysaccharide mimics natural polysaccharides obtained from gram-negative bacteria. The conjugation chemistry employed is thio-ether linkage, and the entire process takes approximately 14-22 hours. These oligosaccharide-protein conjugates are valuable for producing monovalent or multivalent combination vaccines and serve as diagnostic tools.
Career Highlights
Juned Dalal is currently associated with Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. His work at this organization has been instrumental in advancing vaccine development and improving public health outcomes.
Collaborations
He has collaborated with notable colleagues such as Davinder Gill and Manoj Kumar Chhikara, contributing to various projects that enhance the effectiveness of vaccine formulations.
Conclusion
Juned Dalal's innovative work in the field of oligosaccharide-protein conjugation represents a significant advancement in vaccine technology. His contributions are poised to have a lasting impact on immunology and public health.